Cadila Pharmaceuticals Limited — Cefpodoxime Exporter Profile
Indian Pharmaceutical Exporter · #8 for Cefpodoxime · $688.9K export value · DGFT Verified
Cadila Pharmaceuticals Limited is the #8 Indian exporter of Cefpodoxime with $688.9K in export value and 67 verified shipments. Cadila Pharmaceuticals Limited holds a 0.9% market share in Cefpodoxime exports across 10 countries. The company exports 15 pharmaceutical products worth $20.2M across 11 therapeutic categories.
Cadila Pharmaceuticals Limited — Cefpodoxime Export Profile: Buyers & Destinations
Where Does Cadila Pharmaceuticals Limited Export Cefpodoxime?
| Country | Value | Shipments | Share |
|---|---|---|---|
| YEMEN, DEMOCRATIC | $191.2K | 18 | 26.2% |
| NIGERIA | $179.8K | 10 | 24.6% |
| VIETNAM | $86.8K | 4 | 11.9% |
| YEMEN | $71.7K | 4 | 9.8% |
| MAURITIUS | $65.4K | 16 | 9.0% |
| VIETNAM, DEMOCRATIC REP. OF | $41.2K | 4 | 5.6% |
| SUDAN | $32.0K | 2 | 4.4% |
| ZAMBIA | $20.5K | 2 | 2.8% |
| UGANDA | $15.0K | 3 | 2.1% |
| TANZANIA | $14.7K | 2 | 2.0% |
Cadila Pharmaceuticals Limited exports Cefpodoxime to 12 countries. The largest destination is YEMEN, DEMOCRATIC accounting for 26.2% of Cadila Pharmaceuticals Limited's Cefpodoxime shipments, followed by NIGERIA (24.6%) and VIETNAM (11.9%). These destinations reflect Cadila Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cefpodoxime from Cadila Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AL-JABAL DRUGS & MEDICAL APPLIANCES | YEMEN, DEMOCRATIC | $161.0K | 16 |
| INTERPHARMA INDUSTRIES LIMITED | NIGERIA | $82.4K | 4 |
| INTERPHARMA INDUSTRIES LTD | NIGERIA | $61.9K | 3 |
| HOANG TRAN PHARMACEUTICAL TRADING CO LIMITED | VIETNAM | $54.2K | 3 |
| AL-JABAL DRUGS & MEDICAL APPLIACES | YEMEN, DEMOCRATIC | $47.2K | 3 |
| FTM (MAURITIUS) LTD | MAURITIUS | $42.1K | 10 |
| AL-JABAL DRUGS MEDICAL APPLIANCES NOWAKSHOT STREET NR | YEMEN | $41.9K | 2 |
| CAMEL INTERNATIONAL IM-EXPORT CO., | VIETNAM, DEMOCRATIC REP. OF | $41.2K | 4 |
| HOANG TRAN PHARMACEUTICAL TRADING | VIETNAM | $32.6K | 1 |
| PHARMACARE LIMITED | SUDAN | $25.6K | 1 |
Cadila Pharmaceuticals Limited supplies Cefpodoxime to 25 buyers globally. The largest buyer is AL-JABAL DRUGS & MEDICAL APPLIANCES (YEMEN, DEMOCRATIC), followed by INTERPHARMA INDUSTRIES LIMITED (NIGERIA) and INTERPHARMA INDUSTRIES LTD (NIGERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cefpodoxime Export Value and How Much Does Cadila Pharmaceuticals Limited Contribute?
India exported $33.7M worth of Cefpodoxime through 1,734 shipments from 178 suppliers to 78 countries, serving 442 buyers globally. Cadila Pharmaceuticals Limited contributes $688.9K to this total, accounting for 0.9% of India's Cefpodoxime exports. Cadila Pharmaceuticals Limited ships Cefpodoxime to 12 countries through 25 buyers.
What Is the Average Shipment Value for Cadila Pharmaceuticals Limited's Cefpodoxime Exports?
Cadila Pharmaceuticals Limited's average Cefpodoxime shipment value is $10.3K per consignment, based on 67 shipments totaling $688.9K. The largest destination is YEMEN, DEMOCRATIC (26.2% of Cadila Pharmaceuticals Limited's Cefpodoxime exports).
How Does Cadila Pharmaceuticals Limited Compare to Other Indian Cefpodoxime Exporters?
Cadila Pharmaceuticals Limited ranks #8 among 178 Indian Cefpodoxime exporters with a 0.9% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($10.9M), LUPIN LIMITED ($10.6M), AUROBINDO PHARMA LIMITED ($4.5M). Cadila Pharmaceuticals Limited processed 67 shipments to 10 destination countries.
What Cefpodoxime Formulations Does Cadila Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHA DRG & MED CEFTOPIX 100 TAB. CONT. CEFPODOXIME PROXETIL TAB QTY. 20T/PAC | $56.6K | 2 |
| PHA DRG & MED TAMBAC 50 SUSPENSION CONT.CEFPODOXIME PROXETILE QTY. 1PC/PAC | $41.6K | 1 |
| TAMBAC 200 (R/M : CEFPODOXIME PROXETILE) | $36.7K | 2 |
| PHA DRG & MED TAMBAC 200MG TABLET CONT.CEFPODOXIME PROXETIL TAB QTY. 10T/PAC | $36.1K | 2 |
| TAMBAC 50 SUSPENSION (50MG/5ML) (R/M : CEFPODOXIME PROXETILE) BATCH AM70E4001 TO AM70E4002 MFG-MAR-2024 EXP-FEB-2027 | $34.5K | 1 |
| PHA DRG & MED CEFTOPIX 200 (2X10T) CONT.CEFPODOXIME PROXETIL TAB QTY. 20T/PACTBS | $33.2K | 3 |
| TAMBAC 50 SUSPENSION (50MG/5ML) (R/M : CEFPODOXIME PROXETILE) BATCH AM70E3007 TO AM70E3008 MFG-OCT-2023 EXP-SEP-2026NOS | $32.7K | 2 |
| TAMBAC 100 (R/M : CEFPODOXIME PROXETILE) BATCH B2783004A MFG DT-OCT-2023 EXP DT-SEP-2025TBS | $30.5K | 9 |
| TAMBAC 50 SUSPENSION R/M : CEFPODOXIME PROXETILE BATCH AM703003A / AM70E3004-3005 MANUFACTURING : JUN-2023 EXP : MAY-2025 | $29.8K | 1 |
| PODOXIM 200 RAW MATERIAL CEFPODOXIME PROXETILE BATCH B274E5001 B274E5002 | $25.6K | 1 |
Cadila Pharmaceuticals Limited exports 52 distinct Cefpodoxime formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHA DRG & MED CEFTOPIX 100 TAB. CONT. CEFPODOXIME PROXETIL T with 2 shipments worth $56.6K.
Regulatory Requirements: Exporting Cefpodoxime to Key Markets
What Cadila Pharmaceuticals Limited must comply with to export Cefpodoxime to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Cadila Pharmaceuticals Limited Compare to Nearest Cefpodoxime Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | ALKEM LABORATORIES LIMITED | $1.4M | 29 | 5 | $50.0K |
| 7 | MICRO LABS LIMITED | $696.4K | 30 | 3 | $23.2K |
| 8 | CADILA PHARMACEUTICALS LIMITED ★ | $688.9K | 67 | 10 | $10.3K |
| 9 | INNOVA CAPTAB LIMITED | $590.9K | 59 | 7 | $10.0K |
| 6 | MEDINOK HEALTHCARE PRIVATE LIMITED | $500.0K | 10 | 1 | $50.0K |
Cadila Pharmaceuticals Limited ranks #8 among 178 Indian Cefpodoxime exporters. Average shipment value of $10.3K compared to the market average of $189.3K. The closest competitors by value are ALKEM LABORATORIES LIMITED and MICRO LABS LIMITED.
Which Indian Ports Ship Cefpodoxime Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 174 | 10.0% |
| SAHAR AIR | 166 | 9.6% |
| JNPT/ NHAVA SHEVA SEA | 133 | 7.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 128 | 7.4% |
| JNPT | 88 | 5.1% |
| DELHI AIR | 81 | 4.7% |
| HYDERABAD ICD | 79 | 4.6% |
| DELHI AIR CARGO ACC (INDEL4) | 78 | 4.5% |
Geopolitical & Trade Policy Impact on Cadila Pharmaceuticals Limited's Cefpodoxime Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Cadila Pharmaceuticals. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, causing major carriers to suspend or reroute transits. This has resulted in extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes, impacting the timely delivery of pharmaceuticals. (livemint.com)
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. However, the U.S. has also implemented tariffs on Active Pharmaceutical Ingredients (APIs), leading to a reshoring of manufacturing and affecting Indian firms. In response, some Indian companies have invested in U.S. facilities to circumvent these tariffs. (odrindia.in)
In the European Union, compliance with the Falsified Medicines Directive (FMD) has become imperative. Indian exporters must ensure stringent adherence to these regulations to maintain market access, necessitating investments in serialization and traceability systems.
Cadila Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is crucial for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) has previously issued warnings to Cadila Pharmaceuticals regarding deviations from standard manufacturing practices. (business-standard.com) To address such concerns, the company has invested in enhancing its quality control systems and manufacturing processes. Additionally, Cadila has engaged in legal proceedings concerning biosimilar approvals, highlighting the complexities of regulatory compliance in the biosimilars market. (legaleraonline.com)
About Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited exports 15 products worth $20.2M. Beyond Cefpodoxime, top products include Mebendazole, Verapamil, Folic, Domperidone, Ethambutol. View the complete Cadila Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cefpodoxime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cefpodoxime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Cadila Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 69 individual customs records matching Cadila Pharmaceuticals Limited exporting Cefpodoxime, covering 52 formulations to 12 countries via 25 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 78+ countries, 442+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cefpodoxime Export Data from Cadila Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cadila Pharmaceuticals Limited's Cefpodoxime exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Cadila Pharmaceuticals Limited
Full Company Profile →
15 products · $20.2M total trade · 11 categories
Cefpodoxime Stats
Company Overview
Top Products by Cadila Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Cadila Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefpodoxime. For current shipment-level data, contact TransData Nexus.